高机械功率与驱动压与术后呼吸衰竭相关且独立于患者呼吸系统力学
该医院注册研究纳入2008至2020年接受全身麻醉的97,555例成人,4,030例(4.1%)发生术后呼吸衰竭(PRF,定义为7天内再插管或非计划无创通气)。调整分析中,术中高机械功率(≥6.7 J/min)与高驱动压(≥15.0 cm H₂O)均与PRF风险升高相关(aOR 1.37 [95%CI 1.25-1.50];aOR 1.45 [95%CI 1.31-1.60],均p<0.001)。按基线呼吸系统顺应性精确匹配后(机械功率队列63,612例、驱动压队列53,260例,标准化差异=0.00),两者仍与PRF风险升高相关(aOR 1.30 [95%CI 1.17-1.45];aOR 1.28 [95%CI 1.12-1.46],均p<0.001)。作者认为这些发现支持在手术室和ICU用机械功率与驱动压滴定机械通气。
要点
- 全身麻醉成人中,术中高机械功率(≥6.7 J/min,队列中位数)与术后呼吸衰竭风险升高相关(调整后aOR 1.37 [95%CI 1.25-1.50],p<0.001)。
- 术中高驱动压(≥15.0 cm H₂O)与术后呼吸衰竭风险升高相关(调整后aOR 1.45 [95%CI 1.31-1.60],p<0.001)。
- 按基线呼吸系统顺应性精确匹配后,高机械功率与PRF风险升高仍相关(aOR 1.30 [95%CI 1.17-1.45],p<0.001),高驱动压亦如此(aOR 1.28 [95%CI 1.12-1.46],p<0.001)。
- 匹配后两组基线标准化呼吸系统顺应性完全一致(标准化差异=0.00),机械功率为9.4 [2.4] vs 4.9 [1.3] J/min(标准化差异=-2.33),驱动压为19.3 [4.1] vs 11.9 [2.1] cm H₂O(标准化差异=-2.27)。
- 作者认为这些发现支持在手术室和ICU用机械功率与驱动压滴定机械通气。
适用人群与场景
- 2008至2020年间在新英格兰一家学术医院接受全身麻醉的成人患者。
诊断标准与关键阈值
- 主要暴露:高机械功率定义为≥6.7 J/min(队列中位数),对照为低机械功率。
- 关键次要暴露:高驱动压定义为≥15.0 cm H₂O,对照为低驱动压。
- 主要终点术后呼吸衰竭定义为7天内再插管或非计划无创通气。
研究设计与关键结果
- 研究设计为医院注册研究,纳入97,555例接受全身麻醉的成人,其中4,030例(4.1%)发生术后呼吸衰竭。
- 调整分析中,术中高机械功率与术后呼吸衰竭风险升高相关(aOR 1.37 [95%CI 1.25-1.50],p<0.001),高驱动压亦与风险升高相关(aOR 1.45 [95%CI 1.31-1.60],p<0.001)。
- 实施的通气参数因麻醉提供者不同而存在很大变异,据此匹配了63,612例(机械功率队列)和53,260例(驱动压队列)患者,匹配后基线标准化呼吸系统顺应性完全一致(标准化差异=0.00)。
- 匹配后高机械功率组机械功率为9.4 [2.4] vs 4.9 [1.3] J/min(标准化差异=-2.33),高驱动压组驱动压为19.3 [4.1] vs 11.9 [2.1] cm H₂O(标准化差异=-2.27)。
- 匹配后高机械功率仍与术后呼吸衰竭风险升高相关(aOR 1.30 [95%CI 1.17-1.45],p<0.001),高驱动压亦仍相关(aOR 1.28 [95%CI 1.12-1.46],p<0.001)。
证据类型、等级与局限
- 证据类型:医院注册研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,这些发现支持在手术室和ICU用机械功率与驱动压滴定机械通气。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: High mechanical power and driving pressure (ΔP) have been associated with postoperative respiratory failure (PRF) and may be important parameters guiding mechanical ventilation. However, it remains unclear whether high mechanical power and ΔP merely reflect patients with poor respiratory system mechanics at risk of PRF. We investigated the effect of mechanical power and ΔP on PRF in cohorts after exact matching by patients' baseline respiratory system compliance.
DESIGN: Hospital registry study.
SETTING: Academic hospital in New England.
PATIENTS: Adult patients undergoing general anesthesia between 2008 and 2020.
MEASUREMENTS AND MAIN RESULTS: The primary exposure was high (≥ 6.7 J/min, cohort median) versus low mechanical power and the key-secondary exposure was high (≥ 15.0 cm H 2 O) versus low ΔP. The primary endpoint was PRF (reintubation or unplanned noninvasive ventilation within seven days). Among 97,555 included patients, 4,030 (4.1%) developed PRF. In adjusted analyses, high intraoperative mechanical power and ΔP were associated with higher odds of PRF (adjusted odds ratio [aOR] 1.37 [95% CI, 1.25-1.50]; p < 0.001 and aOR 1.45 [95% CI, 1.31-1.60]; p < 0.001, respectively). There was large variability in applied ventilatory parameters, dependent on the anesthesia provider. This facilitated matching of 63,612 (mechanical power cohort) and 53,260 (ΔP cohort) patients, yielding identical baseline standardized respiratory system compliance (standardized difference [SDiff] = 0.00) with distinctly different mechanical power (9.4 [2.4] vs 4.9 [1.3] J/min; SDiff = -2.33) and ΔP (19.3 [4.1] vs 11.9 [2.1] cm H 2 O; SDiff = -2.27). After matching, high mechanical power and ΔP remained associated with higher risk of PRF (aOR 1.30 [95% CI, 1.17-1.45]; p < 0.001 and aOR 1.28 [95% CI, 1.12-1.46]; p < 0.001, respectively).
CONCLUSIONS: High mechanical power and ΔP are associated with PRF independent of patient's baseline respiratory system compliance. Our findings support utilization of these parameters for titrating mechanical ventilation in the operating room and ICU.
参考来源
- Tartler TM, Ahrens E, Munoz-Acuna R, et al. High Mechanical Power and Driving Pressures are Associated With Postoperative Respiratory Failure Independent From Patients' Respiratory System Mechanics. Crit Care Med. 2023. PMID: 37695139. doi:10.1097/CCM.0000000000006038
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。